| DAY 1 - Friday, June 23rd | |
Arrival-Registration | | |
Welcome Introduction | | |
What is New and Interesting in Vascular Access | | |
Moderators: | | |
| | The Nephrologist’s view |
| | The Vascular Surgeon’s view |
| | The Interventional Radiologist’s View |
| | Unmet Needs |
| | Discussion |
Panel: | | |
Trial Updates | | |
Moderators: | | |
| | Studies TBA |
| | Discussion |
Company Symposium | | |
Coffee Break | | |
The Patient in Kidney Replacement Therapy | | |
Moderators: | | |
| | Frailty and its Impact on the Dialysis Patient |
| | The Vascular Access Patient’s View |
| | The Peritoneal Dialysis Patient’s View |
| | The Transplanted Patient’s View |
| | Discussion |
Panel: | | |
Home Dialysis | | |
Moderators: | | |
| | Hemo- and Peritoneal Home Dialysis. Global Overview and Financial Considerations |
| | Home Dialysis is the Future |
| | Home Dialysis Will Never be Established |
| | Discussion |
Panel: | | |
Company Symposium | | |
Percutaneous AVF Creation | | |
Moderators: | | |
| | Current Trends and What we Have Learned so Far |
| | Things I have learned from my Thermal-based AVF Creation Cases |
| | Things I have learned from my RF-based AVF Creation Cases |
|
| Secondary Interventions Case Sharing in Thermal-based AVFs |
| | Secondary Interventions Case Sharing in RF-based AVFs |
| | I Would Still Prefer a Gracz Fistula |
| | Discussion |
Panel: | | |
Collaboration @ EVA | | |
Lunch Break | | |
Amazing Interventions Competition | | |
Moderators: | | |
| | Case 1 |
| | Case 2 |
| | Case 3 |
| | Case 4 |
| | Case 5 |
| | Discussion |
Panel: | | |
The Cardiovascular Implications of Vascular Access | | |
Moderators: | | |
| | The Effects of Dialysis in Blood Pressure |
| | The Clinical Impact to the Heart |
| | Hand Ischemia |
| | Discussion |
Panel: | | |
Company Symposium | | |
Central Venous Stenosis | | |
Moderators: | | |
| | Histopathologic and Hemodynamic Background of Central Venous Disease |
| | Catheter-Related Central Venous Implications |
| | Treatment Options in the Spotlight |
| | Unmasking the Central Venous Stenosis |
| | Don’t Treat it! |
| | Discussion |
Panel: | | |
Collaboration @ EVA | | |
Editor Writing Club | | |
| DAY 2 - Saturday, June 24th | |
Morbidity & Mortality Cases in Vascular Access | | |
Moderators: | | |
| | Case 1 |
| | Case 2 |
| | Case 3 |
| | Case 4 |
| | Discussion |
Panel: | | |
The Way Ahead | | |
Moderators: | | |
| | Titles TBA |
| | Discussion |
Panel: | | |
Company Symposium | | |
Collaboration @ EVA | | |
Coffee Break | | |
Declotting Devices: Available Options | | |
Moderators: | | |
| | Established Debulking Devices |
| | Devices Used in Other Situations That Could Provide a Solution |
| | Thrombolytic Agents. Are They Really Needed? |
| | Antiplatelets and Anticoagulants During and After Thrombectomy. Do they play a role? |
| | Discussion |
Panel: | | |
Company Symposium | | |
Before “First-in-Human” | | |
Moderators: | | |
| | Titles TBA |
| | Discussion |
Panel: | | |
Lunch Break | | |
Guidelines Updates on Vascular Access Treatment | | |
Moderators: | | |
| | Titles TBA |
| | Discussion |
Panel: | | |
Ultrasound in Vascular Access | | |
Moderators: | | |
| | Surgical and Percutaneous AVF Screening |
| | POCUS in Vascular Access |
| | Volume Flow. Is This the Ultimate Tool? |
| | Evaluating Stenotic Types |
| | Ultrasound-Guided Angioplasty |
| | Discussion |
Panel: | | |
Company Symposium | | |
The Financial Reality of Vascular Access Management | | |
Moderators: | | |
| | Medical Device Regulation in the European Union |
| | Financial Analysis for the Use of DCBs in Vascular Access |
| | Cost-Analysis of Covered Stent Use in Vascular Access |
| | Financial Considerations of Percutaneous AVF Creation |
| | Discussion |
Panel: | | |
Peritoneal Dilaysis | | |
Moderators: | | |
| | The Surgical Option |
| | The Percutaneous Option |
| | Periprocedural Complications & Treatment |
| | Long-Term Complications & Treatment |
Panel: | | |
Editor Writing Club by Ziv Haskal (USA) | | |